Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Chaput

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Pancreas|September 1, 1990
Serum apolipoprotein A-I in alcoholic patients with chronic calcifying pancreatitisT Poynard, P Bedossa, P Jais, et al.
Gut|April 1, 1992
Cirrhosis as an independent risk factor for colonic adenomasS Naveau, J C Chaput, P Bedossa, et al.
Clinical Pharmacology and Therapeutics|June 1, 1990
Pharmacokinetics of zidovudine in patients with liver cirrhosisA M Taburet, S Naveau, G Zorza, et al.
Digestive Diseases and Sciences|March 1, 1981
Upper digestive tract hemorrhage in cirrhotic patients. Contribution of multidimensional analysis to the study of variables related to the cause of the hemorrhageT Poynard, J C Chaput, J Y Mary, et al.
Gastroenterologie Clinique Et Biologique|May 1, 1988
[Hepatic involvement in HIV 1 virus infection]C Geffriaud, T Poynard, J F Delfraissy, et al.
Annals of Internal Medicine|November 1, 1987
Adenocarcinoma of the Vater's ampulla and von Recklinghausen diseaseF Paraf, T Poynard, P Bedossa, et al.
Hepatology (Baltimore, Md.)|March 1, 1986
A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patientsS Naveau, G Pelletier, T Poynard, et al.
Hepatology (Baltimore, Md.)|September 1, 1985
Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patientsS Naveau, T Poynard, A Abella, et al.
Vaccine|February 1, 1995
Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccineJ Pillot, T Poynard, A Elias, et al.
European Journal of Gastroenterology & Hepatology|February 2, 2000
A particularly aggressive combined glucagonoma and gastrinoma syndromeA Balian, C Fromont, S Naveau, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Pancreas|September 1, 1990
Serum apolipoprotein A-I in alcoholic patients with chronic calcifying pancreatitisT Poynard, P Bedossa, P Jais, et al.
Gut|April 1, 1992
Cirrhosis as an independent risk factor for colonic adenomasS Naveau, J C Chaput, P Bedossa, et al.
Clinical Pharmacology and Therapeutics|June 1, 1990
Pharmacokinetics of zidovudine in patients with liver cirrhosisA M Taburet, S Naveau, G Zorza, et al.
Digestive Diseases and Sciences|March 1, 1981
Upper digestive tract hemorrhage in cirrhotic patients. Contribution of multidimensional analysis to the study of variables related to the cause of the hemorrhageT Poynard, J C Chaput, J Y Mary, et al.
Gastroenterologie Clinique Et Biologique|May 1, 1988
[Hepatic involvement in HIV 1 virus infection]C Geffriaud, T Poynard, J F Delfraissy, et al.
Annals of Internal Medicine|November 1, 1987
Adenocarcinoma of the Vater's ampulla and von Recklinghausen diseaseF Paraf, T Poynard, P Bedossa, et al.
Hepatology (Baltimore, Md.)|March 1, 1986
A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patientsS Naveau, G Pelletier, T Poynard, et al.
Hepatology (Baltimore, Md.)|September 1, 1985
Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patientsS Naveau, T Poynard, A Abella, et al.
Vaccine|February 1, 1995
Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccineJ Pillot, T Poynard, A Elias, et al.
European Journal of Gastroenterology & Hepatology|February 2, 2000
A particularly aggressive combined glucagonoma and gastrinoma syndromeA Balian, C Fromont, S Naveau, et al.
Pageof 20